Skip to main content
Top
Published in: BMC Infectious Diseases 1/2008

Open Access 01-12-2008 | Research article

Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants

Authors: Belinda Udeh, Chiedozie Udeh, Nicholas Graves

Published in: BMC Infectious Diseases | Issue 1/2008

Login to get access

Abstract

Background

Preventing HIV transmission is a worldwide public health issue. Vertical transmission of HIV from a mother can be prevented with diagnosis and treatment, but screening incurs cost. The U.S. Virgin Islands follows the mainland policy on antenatal screening for HIV even though HIV prevalence is higher and rates of antenatal care are lower. This leads to many cases of vertically transmitted HIV. A better policy is required for the U.S. Virgin Islands.

Methods

The objective of this research was to estimate the cost-effectiveness of relevant HIV screening strategies for the antenatal population in the U.S. Virgin Islands. An economic model was used to evaluate the incremental costs and incremental health benefits of nine different combinations of perinatal HIV screening strategies as compared to existing practice from a societal perspective. Three opportunities for screening were considered in isolation and in combination: by 14 weeks gestation, at the onset of labor, or of the infant after birth. The main outcome measure was the cost per life year gained (LYG).

Results

Results indicate that all strategies would produce benefits and save costs. Universal screening by 14 weeks gestation and screening the infant after birth is the recommended strategy, with cost savings of $1,122,787 and health benefits of 310 LYG. Limitations include the limited research on the variations in screening acceptance of screening based on specimen sample, race and economic status. The benefits of screening after 14 weeks gestation but before the onset of labor were also not addressed.

Conclusion

This study highlights the benefits of offering screening at different opportunities and repeat screening and raises the question of generalizing these results to other countries with similar characteristics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Andiman WA: Transmission of HIV-1 from mother to infant. Current Opinion in Pediatrics. 2002, 14 (1): 78-85. 10.1097/00008480-200202000-00014.CrossRefPubMed Andiman WA: Transmission of HIV-1 from mother to infant. Current Opinion in Pediatrics. 2002, 14 (1): 78-85. 10.1097/00008480-200202000-00014.CrossRefPubMed
2.
go back to reference Public Health Service Task Force – Perinatal HIV Guidelines Working Group: Recommendations for the Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and to Reduce Perinatal HIV-1 Transmission in the United States. HIV/AIDS Treatment Information Service. 2005, U.S. Public Health Service Public Health Service Task Force – Perinatal HIV Guidelines Working Group: Recommendations for the Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and to Reduce Perinatal HIV-1 Transmission in the United States. HIV/AIDS Treatment Information Service. 2005, U.S. Public Health Service
3.
go back to reference Connor EM, Mofenson L: Zidovudine for the reduction of perinatal human-immunodeficiency-virus transmission – Pediatric AIDS Clinical Trials Group Protocol 076 – Results and Treatment Recommendations. Pediatr Infect Dis J. 1995, 14 (6): 536-541.CrossRefPubMed Connor EM, Mofenson L: Zidovudine for the reduction of perinatal human-immunodeficiency-virus transmission – Pediatric AIDS Clinical Trials Group Protocol 076 – Results and Treatment Recommendations. Pediatr Infect Dis J. 1995, 14 (6): 536-541.CrossRefPubMed
4.
go back to reference International Perinatal HIV Group: The mode of delivery and risk of vertical transmission of human immunodeficiency virus type 1: A meta anaysis of 15 prospective cohort studies. New England Journal of Medicine. 1999, 340: 977-987. 10.1056/NEJM199904013401301.CrossRef International Perinatal HIV Group: The mode of delivery and risk of vertical transmission of human immunodeficiency virus type 1: A meta anaysis of 15 prospective cohort studies. New England Journal of Medicine. 1999, 340: 977-987. 10.1056/NEJM199904013401301.CrossRef
5.
go back to reference Gonzague Lallemant, Sophie Le Coeur, Soyeon Kim, Suporn Koetsawang, Marie Anne Comeau, Wiput Phoolcharoen, Max Essex, Kenneth McIntosh, Vicharn Vithayasai: A Trial of Shortened Zidovudine Regimes to Prevent Mother-to-Child Transmission of human Immunodeficiency Virus Type 1. The New England Journal of Medicine. 2000, 343 (14): 982-991. 10.1056/NEJM200010053431401.CrossRef Gonzague Lallemant, Sophie Le Coeur, Soyeon Kim, Suporn Koetsawang, Marie Anne Comeau, Wiput Phoolcharoen, Max Essex, Kenneth McIntosh, Vicharn Vithayasai: A Trial of Shortened Zidovudine Regimes to Prevent Mother-to-Child Transmission of human Immunodeficiency Virus Type 1. The New England Journal of Medicine. 2000, 343 (14): 982-991. 10.1056/NEJM200010053431401.CrossRef
6.
go back to reference Patrick DMM, Deborah M, Jack Forbes, Dobson Siomon RM, Rekart Michael L, Cook Darrel A, Middleton Peter J, Burdge David R: Routine prenatal screening for HIV in a low-prevalence setting. Canadian Medical Association Journal. 1998, 159 (8): 942-947.PubMedPubMedCentral Patrick DMM, Deborah M, Jack Forbes, Dobson Siomon RM, Rekart Michael L, Cook Darrel A, Middleton Peter J, Burdge David R: Routine prenatal screening for HIV in a low-prevalence setting. Canadian Medical Association Journal. 1998, 159 (8): 942-947.PubMedPubMedCentral
7.
go back to reference U.S. Department of Health and Human Services: Recommendations for the Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. 2005, Edited by Force PHST: U.S. Public Health Service U.S. Department of Health and Human Services: Recommendations for the Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. 2005, Edited by Force PHST: U.S. Public Health Service
8.
go back to reference Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe j: Cost effectiveness analysis of antenatal HIV screening in United Kingdom. British Medical Journal. 1999, 319 (7219): 1230-1234.CrossRefPubMedPubMedCentral Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe j: Cost effectiveness analysis of antenatal HIV screening in United Kingdom. British Medical Journal. 1999, 319 (7219): 1230-1234.CrossRefPubMedPubMedCentral
9.
go back to reference Graves N, Walker D, McDonald A, Kaldor J, Ziegler JB: Would Universal Antenatal Screening for HIV Infection be Cost–Effective in a Setting of Very Low Prevalence? Modelling the Data for Australia. Journal of Infectious Diseases. 2004, 190 (1): 166-174. 10.1086/421247.CrossRefPubMed Graves N, Walker D, McDonald A, Kaldor J, Ziegler JB: Would Universal Antenatal Screening for HIV Infection be Cost–Effective in a Setting of Very Low Prevalence? Modelling the Data for Australia. Journal of Infectious Diseases. 2004, 190 (1): 166-174. 10.1086/421247.CrossRefPubMed
10.
go back to reference Mansergh GMA, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M: Cost-effectiveness of Short-Course Zidovudine to Prevent Perinatal HIV Type 1 INfection in a Sub-Saharan African Developing Country Setting. JAMA. 1996, 276 (2): 139-145. 10.1001/jama.276.2.139.CrossRefPubMed Mansergh GMA, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers M: Cost-effectiveness of Short-Course Zidovudine to Prevent Perinatal HIV Type 1 INfection in a Sub-Saharan African Developing Country Setting. JAMA. 1996, 276 (2): 139-145. 10.1001/jama.276.2.139.CrossRefPubMed
11.
go back to reference Soderlund N, Zwi K, Kinghorn A, Gray G: Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. British Medical Journal. 1999, 318 (7199): 1650-1656.CrossRefPubMedPubMedCentral Soderlund N, Zwi K, Kinghorn A, Gray G: Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. British Medical Journal. 1999, 318 (7199): 1650-1656.CrossRefPubMedPubMedCentral
12.
go back to reference Zaric GS, Bayoumi AM, Brandeau ML, Owens DK: The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. Journal of Acquired Immune Deficiency Syndromes. 2000, 25 (5): 403-416. 10.1097/00042560-200012150-00004.CrossRefPubMed Zaric GS, Bayoumi AM, Brandeau ML, Owens DK: The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States. Journal of Acquired Immune Deficiency Syndromes. 2000, 25 (5): 403-416. 10.1097/00042560-200012150-00004.CrossRefPubMed
13.
go back to reference Immergluck LCC, William L, Alan Schwartz, Elstein Arthur S: Cost-Effectiveness of Universal Compared with Voluntary Screening for Human Immunodeficiency Virus Among Pregnant Women in Chicago. Pediatrics. 2000, 105 (4): Immergluck LCC, William L, Alan Schwartz, Elstein Arthur S: Cost-Effectiveness of Universal Compared with Voluntary Screening for Human Immunodeficiency Virus Among Pregnant Women in Chicago. Pediatrics. 2000, 105 (4):
14.
go back to reference Fiscus SA, Schoenback VJ, Wilfer C: Short Courses of Zidovudine and Perinatal Transmission of HIV. New England Journal of Medicine. 1999, 340: 1040-1041. 10.1056/NEJM199904013401312.CrossRefPubMed Fiscus SA, Schoenback VJ, Wilfer C: Short Courses of Zidovudine and Perinatal Transmission of HIV. New England Journal of Medicine. 1999, 340: 1040-1041. 10.1056/NEJM199904013401312.CrossRefPubMed
15.
go back to reference Wade N, Birkhead G, Warren B, Charbonneau T, French T, Wang L, Baum J, Tesoriero J, Savicki R: Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. The New England Journal of Medicine. 1998, 339 (20): 1409-1414. 10.1056/NEJM199811123392001.CrossRefPubMed Wade N, Birkhead G, Warren B, Charbonneau T, French T, Wang L, Baum J, Tesoriero J, Savicki R: Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. The New England Journal of Medicine. 1998, 339 (20): 1409-1414. 10.1056/NEJM199811123392001.CrossRefPubMed
16.
go back to reference Gray G, Chersich MF, Bolton C, Van Niekerk R, Violari A, Stevens W, McIntyre J: A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005, 19: 1289-1297. 10.1097/01.aids.0000180100.42770.a7.CrossRefPubMed Gray G, Chersich MF, Bolton C, Van Niekerk R, Violari A, Stevens W, McIntyre J: A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005, 19: 1289-1297. 10.1097/01.aids.0000180100.42770.a7.CrossRefPubMed
17.
go back to reference Ivery D: Personal Communication – Obstetrician/Gynecologist. 2002, St Croix, U.S. Virgin Islands Ivery D: Personal Communication – Obstetrician/Gynecologist. 2002, St Croix, U.S. Virgin Islands
18.
go back to reference Yeon P: Personal Communication – Infectious Disease Physician. 2002, St Croix, U.S. Virgin Islands Yeon P: Personal Communication – Infectious Disease Physician. 2002, St Croix, U.S. Virgin Islands
20.
go back to reference Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Manacker F, Munson ML: National Vital Statistics Report. 2003, Atlanta: Centers for Disease Control Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Manacker F, Munson ML: National Vital Statistics Report. 2003, Atlanta: Centers for Disease Control
21.
go back to reference Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal. 1996, 313 (7052): 275-283.CrossRefPubMedPubMedCentral Drummond MF, Jefferson TO: Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal. 1996, 313 (7052): 275-283.CrossRefPubMedPubMedCentral
22.
go back to reference Abrams E, Weiner J, Carter R, Kuhn L, Palumbo P, Nesheim S: Maternal Health Factors and Early Pediatric Antiretroviral Therapy Influence the Rate of Perinatal HIV-1 Disease Progression in Children. AIDS. 2003, 17: 867-877. 10.1097/00002030-200304110-00012.CrossRefPubMed Abrams E, Weiner J, Carter R, Kuhn L, Palumbo P, Nesheim S: Maternal Health Factors and Early Pediatric Antiretroviral Therapy Influence the Rate of Perinatal HIV-1 Disease Progression in Children. AIDS. 2003, 17: 867-877. 10.1097/00002030-200304110-00012.CrossRefPubMed
23.
go back to reference European Collaborative Study: Fluctuations in Symptoms in Human Immunodeficiency Virus-Infected Children: The First 10 Years of Life. Pediatrics. 2001, 108 (1): 116-122. 10.1542/peds.108.1.116.CrossRef European Collaborative Study: Fluctuations in Symptoms in Human Immunodeficiency Virus-Infected Children: The First 10 Years of Life. Pediatrics. 2001, 108 (1): 116-122. 10.1542/peds.108.1.116.CrossRef
24.
go back to reference Thorne C, Newell M-L, Botet FA, Bohlin A, Ferrazin A, Giaquinto C, Gomez I, Mok JYQ, Mur A, Peltier A: Older Children and Adolescents Surviving with Vertically Acquired HIV Infection. J Acquir Immune Defic Syndr. 2000, 29 (4): 396-401.CrossRef Thorne C, Newell M-L, Botet FA, Bohlin A, Ferrazin A, Giaquinto C, Gomez I, Mok JYQ, Mur A, Peltier A: Older Children and Adolescents Surviving with Vertically Acquired HIV Infection. J Acquir Immune Defic Syndr. 2000, 29 (4): 396-401.CrossRef
25.
go back to reference Sansom S, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG: Human Immunodeficiency Virus Retesting During Pregnancy: Costs and Effectiveness in Preventing Perinatal Transmission. Obstetrics and Gynecology. 2003, 102 (4): 782-790. 10.1016/S0029-7844(03)00624-0.PubMed Sansom S, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG: Human Immunodeficiency Virus Retesting During Pregnancy: Costs and Effectiveness in Preventing Perinatal Transmission. Obstetrics and Gynecology. 2003, 102 (4): 782-790. 10.1016/S0029-7844(03)00624-0.PubMed
26.
go back to reference Working Group on Mother to Child Transmission of HIV: Rates of mother to child transmission of HIV-1 in Africa, American and Europe: Results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes. 1995, 8: 506-510.CrossRef Working Group on Mother to Child Transmission of HIV: Rates of mother to child transmission of HIV-1 in Africa, American and Europe: Results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes. 1995, 8: 506-510.CrossRef
27.
go back to reference Grobman WA, Garcia PM: The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. American Journal of Obstetrics and Gynecology. 1999, 181 (5 Pt 1): 1062-1071. 10.1016/S0002-9378(99)70082-7.CrossRefPubMed Grobman WA, Garcia PM: The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. American Journal of Obstetrics and Gynecology. 1999, 181 (5 Pt 1): 1062-1071. 10.1016/S0002-9378(99)70082-7.CrossRefPubMed
28.
go back to reference Mrus JM, Tsevat J: Cost-Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal Care. Medical Decision Making. 2004, Jan-Feb: 30-39. 10.1177/0272989X03261570.CrossRef Mrus JM, Tsevat J: Cost-Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal Care. Medical Decision Making. 2004, Jan-Feb: 30-39. 10.1177/0272989X03261570.CrossRef
29.
go back to reference Postma MJB EJ, Mandalia S, Sherr L, Walters MDS, Houweling H, Jager JC: Universal HIV screening of pregnant women in England: cost effectiveness analysis. British Medical Journal. 1999, 318 (7199): 1656-1660.CrossRef Postma MJB EJ, Mandalia S, Sherr L, Walters MDS, Houweling H, Jager JC: Universal HIV screening of pregnant women in England: cost effectiveness analysis. British Medical Journal. 1999, 318 (7199): 1656-1660.CrossRef
30.
go back to reference Havens PL, Cuene BE, Holtgrave DR: Lifetime cost of care for children with human immunodeficiency virus infection. The Pediatric Infectious Disease Journal. 1997, 16 (6): 607-610. 10.1097/00006454-199706000-00012.CrossRefPubMed Havens PL, Cuene BE, Holtgrave DR: Lifetime cost of care for children with human immunodeficiency virus infection. The Pediatric Infectious Disease Journal. 1997, 16 (6): 607-610. 10.1097/00006454-199706000-00012.CrossRefPubMed
31.
go back to reference Wilson L, Moskowitz J, Acree M, Heyman M, Harmatz P, Ferrando S, Folkman S: The Economic Burden of Home Care for Children with HIV and Other Chronic Illnesses. American Journal of Public Health. 2005, 95 (8): 1445-1452. 10.2105/AJPH.2004.044248.CrossRefPubMedPubMedCentral Wilson L, Moskowitz J, Acree M, Heyman M, Harmatz P, Ferrando S, Folkman S: The Economic Burden of Home Care for Children with HIV and Other Chronic Illnesses. American Journal of Public Health. 2005, 95 (8): 1445-1452. 10.2105/AJPH.2004.044248.CrossRefPubMedPubMedCentral
32.
go back to reference Myers ER, Thompson JW, Simpson K: Cost-Effectiveness of Mandatory Compared with Voluntary Screening for Human Immunodeficiency Virus in Pregnancy. Obstetrics and Gynecology. 1998, 91 (2): 174-181. 10.1016/S0029-7844(97)00629-7.CrossRefPubMed Myers ER, Thompson JW, Simpson K: Cost-Effectiveness of Mandatory Compared with Voluntary Screening for Human Immunodeficiency Virus in Pregnancy. Obstetrics and Gynecology. 1998, 91 (2): 174-181. 10.1016/S0029-7844(97)00629-7.CrossRefPubMed
34.
go back to reference Lewis OK: Personal Communication – Nurse. 2002, St Croix, U.S. Virgin Islands Lewis OK: Personal Communication – Nurse. 2002, St Croix, U.S. Virgin Islands
35.
go back to reference Collective Bargaining Agreement Nursing: Nursing Collective Bargaining Agreement Virgin Islands. 2004, U.S. Virgin Islands Collective Bargaining Agreement Nursing: Nursing Collective Bargaining Agreement Virgin Islands. 2004, U.S. Virgin Islands
37.
go back to reference Centers for Disease Control: Update: serologic testing for antibody to human immunodeficiency virus. Morbidity and Mortality Weekly Report. 1988, 36: 833-840. Centers for Disease Control: Update: serologic testing for antibody to human immunodeficiency virus. Morbidity and Mortality Weekly Report. 1988, 36: 833-840.
38.
go back to reference Owens DK, Nease RFJ, Harris RA: Cost-effectiveness of HIV screening in acute care settings. Archives of Internal Medicine. 1996, 156: 394-404. 10.1001/archinte.156.4.394.CrossRefPubMed Owens DK, Nease RFJ, Harris RA: Cost-effectiveness of HIV screening in acute care settings. Archives of Internal Medicine. 1996, 156: 394-404. 10.1001/archinte.156.4.394.CrossRefPubMed
39.
go back to reference Orasure Technologies Inc: OraQuick Advance Rapid HIV-1/2 Antibody Test. 2005, Bethelehem, PA: Orasure Technologies Inc Orasure Technologies Inc: OraQuick Advance Rapid HIV-1/2 Antibody Test. 2005, Bethelehem, PA: Orasure Technologies Inc
40.
go back to reference St Croix HIV and STD Clinic: HIV Testing Bill from St Croix Laboratories. Accounting and Billing Records. 2004, St Croix: U.S. Virgin Islands Department of Health St Croix HIV and STD Clinic: HIV Testing Bill from St Croix Laboratories. Accounting and Billing Records. 2004, St Croix: U.S. Virgin Islands Department of Health
41.
go back to reference Centre for Disease Control and Prevention: Morbidity and Mortality Weekly Report – Revised Guidelines for HIV Conseling, Testing and Referral & Revised Recommendations for HIV Screening in Pregnant Women. 2001, Atlanta: U.S. Department of Health and Human Services Centre for Disease Control and Prevention: Morbidity and Mortality Weekly Report – Revised Guidelines for HIV Conseling, Testing and Referral & Revised Recommendations for HIV Screening in Pregnant Women. 2001, Atlanta: U.S. Department of Health and Human Services
42.
go back to reference Virgin Islands Community AIDS Resource and Education Inc: Personal Communication – Non-profit Organization. 2004, St Croix: VICARE Virgin Islands Community AIDS Resource and Education Inc: Personal Communication – Non-profit Organization. 2004, St Croix: VICARE
44.
go back to reference Ricketts A: Personal Communication. St Croix. 2004 Ricketts A: Personal Communication. St Croix. 2004
45.
go back to reference Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. 2005, UMDNJ, HRSA, NIH Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. 2005, UMDNJ, HRSA, NIH
46.
go back to reference Aynalem G, Mendoza P, Frederick T, Mascola L: Who and Why? HIV-Testing Refusal During Pregnancy: Implication for Pediatric HIV Epidemic Disparity. AIDS and Behavior. 2004, 8 (1): 25-31. 10.1023/B:AIBE.0000017523.39818.88.CrossRefPubMed Aynalem G, Mendoza P, Frederick T, Mascola L: Who and Why? HIV-Testing Refusal During Pregnancy: Implication for Pediatric HIV Epidemic Disparity. AIDS and Behavior. 2004, 8 (1): 25-31. 10.1023/B:AIBE.0000017523.39818.88.CrossRefPubMed
47.
go back to reference Fernandez MI, Wilson TE, Ethier K, Walter E, Gay C, Moore J: Acceptance of HIV Testing During Prenatal Care. Public Health Reports. 2000, Edited by Services USDoHaH, 460-468. 10.1093/phr/115.5.460. Fernandez MI, Wilson TE, Ethier K, Walter E, Gay C, Moore J: Acceptance of HIV Testing During Prenatal Care. Public Health Reports. 2000, Edited by Services USDoHaH, 460-468. 10.1093/phr/115.5.460.
48.
go back to reference Mayaux M, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Ciraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C: Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 in France. Journal of Pediatrics. 1997, 131 (6): 857-862. 10.1016/S0022-3476(97)70033-7.CrossRefPubMed Mayaux M, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Ciraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C: Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 in France. Journal of Pediatrics. 1997, 131 (6): 857-862. 10.1016/S0022-3476(97)70033-7.CrossRefPubMed
49.
go back to reference Bulterys M, Jamieson DJ, O'Sullivan MJ, Cohen M, Maupin R, Nesheim S, Webber MP, Van Dyke RB, Wiener J, Branson B: Rapid HIV-1 Testing During Labor. Journal of American Medical Association. 2004, 292 (2): 219-223. 10.1001/jama.292.2.219.CrossRef Bulterys M, Jamieson DJ, O'Sullivan MJ, Cohen M, Maupin R, Nesheim S, Webber MP, Van Dyke RB, Wiener J, Branson B: Rapid HIV-1 Testing During Labor. Journal of American Medical Association. 2004, 292 (2): 219-223. 10.1001/jama.292.2.219.CrossRef
50.
go back to reference Rajegowda BK, Das BB, Lala R, Rao S, Mc Neeley DF: Expedited human immunodeficiency virus testing of mothers and newborns with unknown HIV status at time of labor and delivery. J Perinat Med. 2000, 28 (6): 458-463. 10.1515/JPM.2000.062.CrossRefPubMed Rajegowda BK, Das BB, Lala R, Rao S, Mc Neeley DF: Expedited human immunodeficiency virus testing of mothers and newborns with unknown HIV status at time of labor and delivery. J Perinat Med. 2000, 28 (6): 458-463. 10.1515/JPM.2000.062.CrossRefPubMed
51.
go back to reference Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG: Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999, 354 (9181): 803-809. 10.1016/S0140-6736(99)80009-9.CrossRefPubMed Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG: Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999, 354 (9181): 803-809. 10.1016/S0140-6736(99)80009-9.CrossRefPubMed
52.
go back to reference Office of HIV/AIDS Surveillance: HIV/AIDS Surveillance Quarterly Report. 2002, St Thomas, Virgin Islands: Virgin Islands Department of Health Office of HIV/AIDS Surveillance: HIV/AIDS Surveillance Quarterly Report. 2002, St Thomas, Virgin Islands: Virgin Islands Department of Health
53.
go back to reference Kirshenbaum SB, Hirky AE, Correale J, Goldstein RB, Johnson MO, Rotheram-Borus MJ, Ehrhardt AA: "Throwing the Dice": Pregnancy Decision-Making Among HIV-Positive Women in Four U.S. Cities. Perspectives on Sexual & Reproductive Health. 2004, 36 (3): 106-113. 10.1363/3610604.CrossRef Kirshenbaum SB, Hirky AE, Correale J, Goldstein RB, Johnson MO, Rotheram-Borus MJ, Ehrhardt AA: "Throwing the Dice": Pregnancy Decision-Making Among HIV-Positive Women in Four U.S. Cities. Perspectives on Sexual & Reproductive Health. 2004, 36 (3): 106-113. 10.1363/3610604.CrossRef
54.
go back to reference Mofenson L, Lambert JS, Steihm R: Risk factors of perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine. 1999, 341: 385-393. 10.1056/NEJM199908053410601.CrossRefPubMed Mofenson L, Lambert JS, Steihm R: Risk factors of perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. New England Journal of Medicine. 1999, 341: 385-393. 10.1056/NEJM199908053410601.CrossRefPubMed
55.
go back to reference Galli L, Demartino M, Tovo PA, Gabiano C, Zappa M, Giaquinto C, Tulisso S, Vierucci A, Guerra M, Marschisio P: Onset of Clinical Signs in Children with HIV-1 Perinatal Infection. AIDS. 1995, 9 (5): 455-461. 10.1097/00002030-199509050-00007.CrossRefPubMed Galli L, Demartino M, Tovo PA, Gabiano C, Zappa M, Giaquinto C, Tulisso S, Vierucci A, Guerra M, Marschisio P: Onset of Clinical Signs in Children with HIV-1 Perinatal Infection. AIDS. 1995, 9 (5): 455-461. 10.1097/00002030-199509050-00007.CrossRefPubMed
56.
go back to reference Morris CR, Araba-Owoyele L, Sector S, Maldonado Y: Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 1996, 15 (4): 321-328. 10.1097/00006454-199604000-00008.CrossRefPubMed Morris CR, Araba-Owoyele L, Sector S, Maldonado Y: Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 1996, 15 (4): 321-328. 10.1097/00006454-199604000-00008.CrossRefPubMed
57.
go back to reference Sculpher MJ, Gibb D, Ades AE, Ratcliffe J, Duong T: Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers. AIDS. 1998, 12: 1371-1380. 10.1097/00002030-199811000-00020.CrossRefPubMed Sculpher MJ, Gibb D, Ades AE, Ratcliffe J, Duong T: Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers. AIDS. 1998, 12: 1371-1380. 10.1097/00002030-199811000-00020.CrossRefPubMed
58.
go back to reference Gibb DM, Ades AE, Ramyani Gupta, Sculpher Mark J: Cost and benefits to the mother of antenatal HIV testing: estimates from simulation modelling. AIDS. 1999, 13 (12): 1569-1576. 10.1097/00002030-199908200-00018.CrossRefPubMed Gibb DM, Ades AE, Ramyani Gupta, Sculpher Mark J: Cost and benefits to the mother of antenatal HIV testing: estimates from simulation modelling. AIDS. 1999, 13 (12): 1569-1576. 10.1097/00002030-199908200-00018.CrossRefPubMed
Metadata
Title
Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants
Authors
Belinda Udeh
Chiedozie Udeh
Nicholas Graves
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2008
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-8-174

Other articles of this Issue 1/2008

BMC Infectious Diseases 1/2008 Go to the issue